Aspen Grove Capital, LLC Astrazeneca PLC Transaction History
Aspen Grove Capital, LLC
- $594 Billion
- Q3 2025
A detailed history of Aspen Grove Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Aspen Grove Capital, LLC holds 4,419 shares of AZN stock, worth $395,058. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,419
Previous 6,420
31.17%
Holding current value
$395,058
Previous $449 Million
24.43%
% of portfolio
0.06%
Previous 0.08%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...